I apologize for the length, but do some DD on what I'm

New Post Public Reply Private Reply Replies (0) Message Board
postal lady
256
I apologize for the length, but do some DD on what I'm showing you.....if you need any links I will be happy to provide them.

The Delaware County, PA case (CV-2019-008314) is the proof of concept. It confirms that the promoters have used this exact setup before:

Solicit capital for a "cannabis patch."
Claim impending mergers with Univec and imminent distribution deals with doctors and pharmacies.
Quietly move the capital while the product fails to materialize, eventually going silent when investors ask hard questions.
By analyzing the current 11 Three pitch deck through the lens of their past legal dockets, I stripped away the high-tech pharmaceutical facade to reveal a simple, unpatented retail CBD patch wrapped in a familiar capital-raising scheme. The press release explicitly states: "11 Three LLC is an advanced transdermal technology partner based at the University of Maryland BioPark in Baltimore, MD." . 
The pitch deck states that their performance is "verified" by the University of Maryland Applied Pharmaceutics Lab (APhL).

The Reality: APhL is a fee-for-service, contract testing lab housed within the School of Pharmacy. It functions like a commercial business.
Anyone...from a large pharma company to a local startup, or even a random individual—can pay a fee, send them a sample, and have them run basic physical testing (such as adhesive peel-strength or standard chemical analysis).
The promoters pay a small fee for basic, standard lab testing of their generic patch adhesive, and then spin that transaction in their pitch deck as "Institutional validation and scientific testing verified by the University of Maryland." Institutional Validation vs. Fee-For-Service


There is a massive legal and scientific difference between scientific testing and institutional validation:
Institutional Validation/Endorsement: This means the University itself sponsors, co-develops, or officially stands behind the technology, usually through exclusive patent licensing deals or clinical trial partnerships.

If this were true, there would be official press releases from the University, and searching "Reliefta" or "11 Three" on the school's website would yield research papers, articles, or official directory listings.

My Search Result: Returned absolutely zero results proves the University of Maryland does not recognize, license, or officially endorse "Reliefta." The school has no official association with the product. The name "Reliefta" does not exist in any of their scientific registries or official databases.
I've proved the "SENDS" patent application was ceased/abandoned.
Proved there is no FDA-registered NDC number for the product.
And now, I've proved that the University of Maryland has zero record of the technology or product they claim was "institutionally validated."

This exposes how absurd the 11 Three / Univec pitch really is.

When you look at the multi-billion-dollar titans of the industry—companies like Jazz Pharmaceuticals (which bought GW Pharmaceuticals for $7.2 billion) and pioneers like Mary’s Medicinals—they own the actual, legally defensible, and heavily guarded patents for transdermal cannabinoid delivery.

Yet, despite their billions of dollars, army of lawyers, and massive research facilities, none of them have ever gotten an FDA-approved, insurance-reimbursable NDC for a cannabinoid patch.

The Giants with Actual IP Failed to Get a Patch NDC
Mary’s Medicinals: They are the undisputed, original pioneers of the commercial cannabis transdermal patch (holding key patents on transdermal delivery of cannabinoids). Despite their massive market share in legal state dispensaries, they operate strictly in the state-regulated cannabis/supplement space. They do not have—and have never claimed to have—an FDA-approved prescription NDC number for their patches because the FDA does not recognize them as prescription drugs.

Jazz/GW Pharmaceuticals: GW Pharmaceuticals spent decades and hundreds of millions of dollars successfully pushing Epidiolex (an oral solution) through the grueling FDA Phase III trial pipeline to get the only real plant-derived cannabinoid NDC in US history. They also poured immense resources into trying to get Sativex (an oral spray) approved in the US, but faced massive clinical trial hurdles. If a transdermal patch were a viable, fast-track shortcut to a prescription NDC, a $7.2 billion pharmaceutical behemoth like Jazz/GW would have dominated that space years ago.

Landrace tried to copy and change some wording...smaller operations look at the highly complex, valid patent portfolios of companies like Mary's Medicinals or academic institutions. They try to draft a "new" patent application (like the SENDS platform) by slightly altering the chemical carrier, the surfactant ratios, or the legal verbiage to make it look like a unique, proprietary invention to unsophisticated investors.

The USPTO (Patent Office) easily spots these recycled formulations, which is why the Landrace "SENDS" patent application was officially Ceased and Abandoned. They couldn't get the patent approved because the actual science of putting cannabinoids into transdermal carriers is already heavily patented by the real players, or it exists in the public domain.

If the global giants with the actual patents, the scientific infrastructure, and the billions in capital couldn't get a cannabinoid patch approved by the FDA as an insurance-reimbursable prescription drug, how on earth is a non-existent LLC with a broken email address and an abandoned patent going to do it?

PL

395270200_Screenshot2026-07-148.47.52AM.png

263426017_Screenshot2026-07-201.35.07PM.png
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Santa Ana Branch Expansion Tests Local Credit Demand

Updated Category News Views 28

A Bigger Room for Smaller Financial Decisions A branch relocation across the same shopping center may sound mundane, but it says plenty about where California Credit Union sees durable demand. The credit union has opened a larger Santa Ana office at 1601 W. 17th Street, Suite C, replacing its prior spot in the same center. This is not some chest-thumping expansion into an...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 15

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
HiTHIUM's 8-Hour Storage Pitch Faces Real Grid Tests

Updated Category News Views 136

Eight hours of stored electricity is where the sales brochure meets the ugly parts of the grid. HiTHIUM arrived at RE+ 2026 in Las Vegas, held November 17 through 19, with a broad storage pitch: systems ranging from two to eight hours, lithium-ion and sodium-ion chemistry, plus the software and validation work needed to make a battery plant behave when the local grid gets...

Continue Reading
Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 155

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
Gildan Lawsuit Puts Revenue Controls Under a Harsh Light

Updated Category News Views 36

Receivables have a nasty way of becoming everybody’s problem once the story cracks. Gildan Activewear is staring at that uncomfortable reality after a securities fraud class action was filed on behalf of investors who bought or acquired shares between February 19, 2025 and June 15, 2026. The case, Cortez v. Gildan Activewear Inc., is pending in the U.S. District Court...

Continue Reading
Roof Leaks Demand Diagnosis Before the Repair Bill

Updated Category News Views 95

A brown ring on a ceiling is often the last witness, not the crime scene. That is the useful, unglamorous point in Jonathan Floyd's HelloNation discussion of roof leaks: water has plenty of ways to move after it slips past a roof's defenses. Homeowners understandably stare at the stain and assume the answer sits directly overhead. Sometimes it does. Plenty of times, it...

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 126

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
APEC in Shenzhen Puts Trade Openness Back in Focus

Updated Category News Views 80

Shenzhen is hosting a familiar but consequential argument: prosperity gets harder to share when trade channels clog up. At the 33rd Asia-Pacific Economic Cooperation Economic Leaders' Meeting on November 18, President Xi Jinping used the opening of the APEC CEO Summit to argue for peace, openness, innovation, mutual benefit and support for the WTO-centered multilateral...

Continue Reading
Specialized Metal Makers Become the New M&A Prize Again

Updated Category News Views 14

A forgotten heat-treatment line can suddenly be worth more than a shiny new mill when buyers realize nobody can duplicate its certifications, workforce, and customer approvals overnight. That is the basic truth sitting underneath BGL's Nov. 19, 2026 assessment of the U.S. metals market. The easy headline is consolidation. The useful takeaway is much narrower: specialized...

Continue Reading
Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 18

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading

Top 5 Most Recently Viewed Articles

Telegram Embraces AI and User Transparency Amid Legal Struggles

Updated Category News Views 456

Telegram's Shift Towards Security and Legal Compliance Recently, Telegram's CEO Pavel Durov has announced new measures to improve the platform's adherence to legal requirements, which includes the decision to share user IP addresses and phone numbers with authorities when faced with valid legal requests. This represents a significant departure from Telegram's long-held...

Continue Reading
Lawsuit Against Sable Offshore Accuses Misleading Practices

Updated Category News Views 220

Sable Offshore Faces Legal Actions for Misleading Investors In recent developments, Sable Offshore Corp. (SOC) has been embroiled in a securities class-action lawsuit, claiming that the company deceived investors regarding its oil production activities. This lawsuit, which has drawn significant attention, was filed in federal court and signals serious allegations against...

Continue Reading
Innovative Industrial Properties Investors Face Class Action Deadline

Updated Category News Views 115

Innovative Industrial Properties: Class Action Lawsuit Notification The legal landscape for investors can often seem daunting, particularly when class action lawsuits arise. Recently, Innovative Industrial Properties, Inc. (IIPR) found itself at the center of such a lawsuit, prompting a call to action for affected investors. The law firm Faruqi & Faruqi, LLP, a...

Continue Reading
Hisense Launches HT SATURN Sound System for Home Entertainment

Updated Category News Views 672

Introducing the HT SATURN Home Theatre Sound System In a remarkable step towards redefining home audio systems, Hisense has unveiled the HT SATURN, a cutting-edge 4.1.2?channel surround sound system. This innovative product showcases the exclusive "Tuned by Devialet" certification, ensuring a truly immersive listening experience. The HT SATURN combines Hisense's advanced...

Continue Reading
Groundbreaking Study Shows Benefits of Human Milk Diet for Preemies

Updated Category News Views 510

Revolutionary Findings on Exclusive Human Milk Diet The Impact of Human Milk on Preemie Development A recent study has shed light on the incredible benefits of the Exclusive Human Milk Diet (EHMD) provided by Prolacta Bioscience. This research indicates that premature infants, who typically face numerous developmental challenges due to being born early and less weighty,...

Continue Reading